Bolstering Diversity in Clinical Trials

Clinical trials have a diversity problem, and it could be having a negative impact on their ability to secure FDA approval. Here’s what you need to know.

Steps to Take Before Beginning Clinical Trial Recruitment

The old saying that “hindsight is better than foresight” may not be the best strategy to follow when it comes to clinical trials. While learning from past mistakes can be helpful, in this case it is far better to look ahead and try to minimize the amount of problems that may occur. Far too much […]

Updating NIMH’s Points to Consider for Clinical Trial Recruitment

In June of 2005 the National Institute of Mental Health (NIMH) released its “Points to Consider about Recruitment and Retention While Preparing a Clinical Research Study.” While many of the points it outlines are still quite valid, some of the suggestions need to be updated, especially in light of the many incredibly effective digital marketing […]

Capitalize on Better Clinical Trial Design with Improved Clinical Trial Recruitment

An August 13 Forbes.com article by Henry I. Miller and S. Stanley Young asked whether designing better clinical trials would be helpful in lowering development costs and yielding more new pharmaceuticals. The authors urged designers of clinical trials to think outside the box to reduce the various diversity gaps in trial participants and moderate the […]

Can Savvy Marketing Solve the Problem of Low Clinical Trial Recruitment?

Pharmaceutical-technology.com recently posted an item about the abysmal results of clinical trial recruitment. The article reported that 15-20% of trials never get off the ground, simply because they are unable to enroll a single participant! Furthermore, the article reported on an alarming drop in patient enrollment and retention rates, with more than two-thirds of trial […]